![]() | Up a level |
2020
Meiberth, D., Hu, X., Schild, A. K., Spottke, A., Brosseron, F., Buerger, K., Fliessbach, K., Heneka, M. T., Kilimann, I, Laske, C., Peters, O., Priller, J., Schneider, A., Teipel, S., Wiltfang, J., Wagner, M., Duezel, E. and Jessen, F. (2020). Alzheimer's Disease biomarkers and cortical thickness in persons reporting subjective cognitive decline and healthy controls: Data derived from the DZNE DELCDODE-Study. Pharmacopsychiatry, 53 (2). S. 83 - 84. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-0795
2016
van der Zee, J., Gijselinck, I., Van Mossevelde, S., Perrone, F., Engelborghs, S., De Bleecker, J., Baets, J., Gelpi, E., Rojas-Garcia, R., Clarimon, J., Lleo, A., Diehl-Schmid, J., Alexopoulos, P., Perneczky, R., Synofzik, M., Just, J., Schoels, L., Graff, C., Thonberg, H., Borroni, B., Padovani, A., Jordanova, A., Sarafov, S., Tournev, I., de Mendonca, A., Miltenberger-Miltenyi, G., Simoes do Couto, F., Ramirez, A., Jessen, F., Heneka, M. T., Gomez-Tortosa, E., Danek, A., Cras, P., Vandenberghe, R., De Jonghe, P., De Deyn, P. P., Sleegers, K., Cruts, M. and Van Broeckhoven, C. (2016). TBK1 loss-of function and dominant-negative mutations in an extended European cohort of FTD and ALS patients. J. Neurochem., 138. S. 304 - 306. HOBOKEN: WILEY-BLACKWELL. ISSN 1471-4159